SCHEMBL22669377

SCHEMBL22669377

CCc1cc(=O)n(C)[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5975794 0.83 KDM4E (0.47) —
SCHEMBL23402985 0.79 DAO (0.46) —
SCHEMBL23399589 0.77 MEN1 (0.42) —
SCHEMBL23401931 0.77 MEN1 (0.46) —
SCHEMBL23398798 0.74 MEN1 (0.55) —
SCHEMBL23400008 0.72 DAO (0.35) —
SCHEMBL23398944 0.72 DAO (0.35) —
SCHEMBL23399923 0.71 ALDH1A1 (0.35) —
SCHEMBL15196007 0.70 YTHDF2 (0.47) —
SCHEMBL12297443 0.69 KMT2A (0.64) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021229571-A1 IMIDAZOLE 3-OXIDE DERIVATIVE BASED ACSS2 INHIBITORS AND METHODS OF USE THEREOF METABOMED LTD (IL) 2021-11-18 — — WO disclosed
EP-3828159-A1 STORAGE AND TRANSPORT STABILIZERS FOR POLYMERIZABLE COMPOUNDS BASF SE (DE) 2021-06-02 — — EP disclosed
WO-2020230136-A1 ACSS2 INHIBITORS AND METHODS OF USE THEREOF METABOMED LTD (IL) 2020-11-19 — — WO disclosed
Send feedback